Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


[A 55-year old Thai male patient with acute right upper quadrant abdominal pain].

Lindner A, Weber C, Rittweger M, Stocker H, Arastéh K.

Internist (Berl). 2015 Aug;56(8):944-8. doi: 10.1007/s00108-015-3750-8. German.


Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group.; Royal Free Hospital Clinic Cohort.; INSIGHT study group.; SMART study group.; ESPRIT study group..

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.


Teaching Video NeuroImages: focal cortical myoclonus in progressive multifocal leukoencephalopathy.

Rittweger M, Branding G, Arastéh K, Grosse P, Katchanov J.

Neurology. 2014 Sep 23;83(13):e132. doi: 10.1212/WNL.0000000000000826. No abstract available.


Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups.; SILCAAT Scientific Committee..

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.


Interactive exploration of integrated biological datasets using context-sensitive workflows.

Horn F, Rittweger M, Taubert J, Lysenko A, Rawlings C, Guthke R.

Front Genet. 2014 Feb 20;5:21. doi: 10.3389/fgene.2014.00021. eCollection 2014.


Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

Yuan J, Guo S, Hall D, Cammett AM, Jayadev S, Distel M, Storfer S, Huang Z, Mootsikapun P, Ruxrungtham K, Podzamczer D, Haas DW; Nevirapine Toxicogenomics Study Team..

AIDS. 2011 Jun 19;25(10):1271-80. doi: 10.1097/QAD.0b013e32834779df.


Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group.; SILCAAT Scientific Committee., Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.


Clinical pharmacokinetics of darunavir.

Rittweger M, Arastéh K.

Clin Pharmacokinet. 2007;46(9):739-56. Review.


Supplemental Content

Loading ...
Support Center